Inhaled corticosteroids only decrease on the lymphocytes PGP expression and antileukotrienes mrp expression in asthmatic children after one month treatment

J. Potesil, F. Kopriva, P. Dzubak, M. Hajduch (Olomouc, Czech Republic)

Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Session: Aspects of uncontrolled asthma
Session type: Thematic Poster Session
Number: 1981
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Potesil, F. Kopriva, P. Dzubak, M. Hajduch (Olomouc, Czech Republic). Inhaled corticosteroids only decrease on the lymphocytes PGP expression and antileukotrienes mrp expression in asthmatic children after one month treatment. Eur Respir J 2009; 34: Suppl. 53, 1981

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003

Increased sputum FKBP51 gene expression following Azithromycin add-on therapy in asthma
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018



Effects of childhood asthma and inhaled corticosteroid treatment on EBC levels of IL-4 and TNF-α
Source: Eur Respir J 2005; 26: Suppl. 49, 227s
Year: 2005

Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 258s
Year: 2006

The effect of inhaled budesonide on MMP-8 and TIMP-1 expression in induced sputum of asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 595s
Year: 2004

Inhaled steroids in the treatment of newly detected asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002



Reduction of inhaled corticosteroids in asthmatic children
Source: Eur Respir J 2007; 30: Suppl. 51, 616s
Year: 2007

Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011


Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
Source: Eur Respir J 2006; 27: 1144-1151
Year: 2006



Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma
Source: Eur Respir J 2009; 33: 1277-1286
Year: 2009



High sputum eosinophils are associated with better response to inhaled corticosteroids in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002

Meta-analysis of inhaled corticosteroids response in children with asthma.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019


Safety of inhaled corticosteroids reduction in asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Inhaled corticosteroid (ICS) induced metabolome changes in asthmatics.
Source: Virtual Congress 2020 – Cutting edge science: novel molecules and mechanisms of airway diseases
Year: 2020




Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

The effect of inhaled corticosteroids on airway mast cells in type 2 low asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020